影像组学分析预测局部晚期胰腺癌立体定向体部放疗后的局部反应
本回顾性研究分析37例接受立体定向体部放疗的胰腺癌患者的增强CT影像,采用27个影像组学特征和2个临床变量构建预测局部反应的模型。多因素分析显示GLCM25_Correlation(P=0.007)和NID25_Busyness(P=0.03)为独立预测变量,模型AUC为0.851(95%CI 0.724-0.978)。中位随访30个月时,中位无进展生存期为7个月(95%CI 6-NA),中位总生存期为11个月(95%CI 10-22个月)。
要点
- 增强CT影像组学特征GLCM25_Correlation和NID25_Busyness与局部反应独立相关。
- 多变量 logistic 回归模型预测局部反应的AUC为0.851(95%CI 0.724-0.978)。
- 中位随访30个月,中位无进展生存期7个月,中位总生存期11个月。
核心结论
- 影像组学特征与局部反应相关,但需前瞻性研究确认以识别不同放疗剂量反应率的患者亚组,从而定义更个性化的SBRT方案。
研究设计与样本
- 回顾性队列研究,纳入37例接受SBRT的胰腺癌患者,分析增强CT图像,纳入2个临床变量(BED、CTV体积)和27个影像组学特征,以局部反应为结局变量构建预测模型,采用Kaplan-Meier法评估PFS和OS。
诊断标准与关键数值
- 单因素分析中与局部反应统计学相关的变量为强度直方图StdValue特征、灰度共生矩阵GLCM25_Correlation特征和邻域强度差NID25_Busyness特征;多变量模型中GLCM25_Correlation(P=0.007)和NID25_Busyness(P=0.03)为独立预测变量,OR分别为0.07(95%CI 0.01-0.49)和8.10(95%CI 1.20-54.40);多变量logistic回归模型AUC为0.851(95%CI 0.724-0.978)。
临床应用与阅片要点
- 作者认为需前瞻性研究确认结果,以识别不同放疗剂量反应率的患者亚组,定义更个性化的SBRT方案。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Aim of this study is to assess the ability of contrast-enhanced CT image-based radiomic analysis to predict local response (LR) in a retrospective cohort of patients affected by pancreatic cancer and treated with stereotactic body radiation therapy (SBRT). Secondary aim is to evaluate progression free survival (PFS) and overall survival (OS) at long-term follow-up.
METHODS: Contrast-enhanced-CT images of 37 patients who underwent SBRT were analyzed. Two clinical variables (BED, CTV volume), 27 radiomic features were included. LR was used as the outcome variable to build the predictive model. The Kaplan-Meier method was used to evaluate PFS and OS.
RESULTS: Three variables were statistically correlated with the LR in the univariate analysis: Intensity Histogram (StdValue feature), Gray Level Cooccurrence Matrix (GLCM25_Correlation feature) and Neighbor Intensity Difference (NID25_Busyness feature). Multivariate model showed GLCM25_Correlation (P = 0.007) and NID25_Busyness (P = 0.03) as 2 independent predictive variables for LR. The odds ratio values of GLCM25_Correlation and NID25_Busyness were 0.07 (95%CI 0.01-0.49) and 8.10 (95%CI 1.20-54.40), respectively. The area under the curve for the multivariate logistic regressive model was 0.851 (95%CI 0.724-0.978). At a median follow-up of 30 months, median PFS was 7 months (95%CI 6-NA); median OS was 11 months (95%CI 10-22 months).
CONCLUSIONS: This analysis identified a radiomic signature that correlates with LR. To confirm these results, prospective studies could identify patient sub-groups with different rates of radiation dose-response to define a more personalized SBRT approach.
引用
- Gregucci, Fiorentino, Mazzola, et al. Radiomic analysis to predict local response in locally advanced pancreatic cancer treated with stereotactic body radiation therapy. Radiol Med. 2021. PMID: 34724139. doi:10.1007/s11547-021-01422-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。